InsiderClue
← All stocks

GeneDx Holdings Corp.

WGS Scheduled selling only
CIK 0001818331 #1896 in the set updated 21 Sep 2026
Bought (1 mo)
$0.00
out of their own pocket, the only kind of buying there is
Sold (1 mo)
$1.84M
$0.00 on a plan · $1.84M straight out of an exercise
Sold at will
$0.00
0 of 13 sales
Net
−$1.84M
$0.00 against sales at will

By person

12 insiders · 13 transactions
15.9×

Katherine Stueland holds 15.9 times base salary in stock. $11.43M of shares against $715.87K in salary for 2025.

Salary from the company's own proxy. The shares are what Katherine Stueland last reported holding, valued at $99.00, the price Class A Common Stock was last bought or sold at on the open market here, on 16 Sep 2026.

Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
Stueland Katherine
CHIEF EXECUTIVE OFFICER
—
$1.34M (6) scheduled
−$1.34M
115,476
0.3872%
$11.43M
+11.3%
Feeley Kevin
CHIEF FINANCIAL OFFICER
—
$503.30K (7) scheduled
−$503.30K
44,945
0.1507%
$4.45M
−49.8%
Meister Keith A.
Director
—
—
—
4,808,275
16.12%
$476.00M
+93.8%
Casdin Capital, LLC entity
Director
—
—
—
3,707,164
12.43%
$366.99M
+5.7%
ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI
10% owner
—
—
—
2,719,692
9.12%
$269.24M
−27.1%
RUCH JOSHUA
Director
—
—
—
153,382
0.5143%
$15.18M
−7.6%
Ryan Jason
Director
—
—
—
118,764
0.3982%
$11.76M
−64.0%
PFENNIGER RICHARD C JR
Director
—
—
—
45,082
0.1512%
$4.46M
+63.0%
Leproust Emily M.
Director
—
—
—
24,852
0.0833%
$2.46M
+197.6%
Casdin Eli
Director
—
—
—
24,093
0.0808%
$2.39M
+217.3%
Fuchs Thomas
Director
—
—
—
1,146
0.0038%
$113.45K
—
Dechairo Bryan
Chief Operating Officer
—
—
—
0
0.0000%
$0.00
—

Individual transactions

13
Insider
Date
Role
Action
Shares
Price
Amount
Stueland Katherine
16 Sep 2026
CHIEF EXECUTIVE OFFICER
Sold after exercise
3,039
$99.00
$300.85K
Stueland Katherine
16 Sep 2026
CHIEF EXECUTIVE OFFICER
Sold after exercise
4,141
$98.27
$406.94K
Stueland Katherine
16 Sep 2026
CHIEF EXECUTIVE OFFICER
Sold after exercise
1,525
$96.90
$147.77K
Stueland Katherine
16 Sep 2026
CHIEF EXECUTIVE OFFICER
Sold after exercise
148
$95.41
$14.12K
Stueland Katherine
16 Sep 2026
CHIEF EXECUTIVE OFFICER
Sold after exercise
1,648
$94.26
$155.34K
Feeley Kevin
16 Sep 2026
CHIEF FINANCIAL OFFICER
Sold after exercise
1,079
$99.00
$106.82K
Feeley Kevin
16 Sep 2026
CHIEF FINANCIAL OFFICER
Sold after exercise
1,470
$98.27
$144.46K
Feeley Kevin
16 Sep 2026
CHIEF FINANCIAL OFFICER
Sold after exercise
541
$96.90
$52.42K
Feeley Kevin
16 Sep 2026
CHIEF FINANCIAL OFFICER
Sold after exercise
52
$95.41
$4.96K
Feeley Kevin
16 Sep 2026
CHIEF FINANCIAL OFFICER
Sold after exercise
586
$94.26
$55.24K
Stueland Katherine
9 Sep 2026
CHIEF EXECUTIVE OFFICER
Sold after exercise
3,692
$84.22
$310.93K
Feeley Kevin
9 Sep 2026
CHIEF FINANCIAL OFFICER
Sold after exercise
1,285
$84.22
$108.22K
Feeley Kevin
1 Sep 2026
CHIEF FINANCIAL OFFICER
Sold after exercise
372
$83.84
$31.19K
Show all 13 transactions →

What was left out

Form 4 filings counted 6
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 13
Sales at will 0
Transactions with no price 0
Shares from compensation/vesting 36,819
History held since 26 Jul 2021